Financial Year |
March 31 2023 |
Monetary Funds |
12,605,050,518.34 |
Held-for-trading Financial Assets |
-- |
Notes Receivable |
629,577,371.14 |
Accounts Receivable |
6,793,938,568.09 |
Advances to Suppliers |
3,472,790,599.30 |
Other Receivables |
31,709,837,779.80 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
320,550,606.07 |
Inventories |
149,859,929,283.41 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
18,222,300,298.05 |
Total Current Assets |
241,388,480,166.86 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
17,528,673,134.79 |
Investment Properties |
8,953,327,837.84 |
Fixed Assetes |
3,233,270,488.46 |
Under-construction Projects |
96,698,251.77 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
646,428,060.46 |
R&D expenses |
-- |
Goodwill |
4,188,653.58 |
Long-Term Deferred and Prepaid Expenses |
181,203,656.38 |
Deferred Income Tax Assets |
3,979,601,523.82 |
Other Non-Current Assets |
20,722,878,805.00 |
Sub-Total of Non-Current Assets |
56,533,592,038.58 |
Total Assets |
297,922,072,205.44 |
Short-Term Loans |
7,833,059,095.48 |
Trading Financial liabilities |
-- |
Notes Payable |
6,772,532,974.99 |
Accounts Payable |
34,756,732,032.52 |
Accounts Received In Advance |
46,778,710.80 |
Employee Compensation Payable |
59,436,533.08 |
Taxes Payable |
8,366,082,916.13 |
Interest Payable |
-- |
Dividend Payable |
15,248,434.90 |
Other payables |
43,970,716,243.89 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
14,505,675,953.20 |
Other Current Liabilities |
11,619,951,081.43 |
Sub-Total of Current Liabilities |
243,865,671,616.40 |
Long-term Loans |
20,637,314,045.69 |
Bonds Payable |
4,073,374,600.66 |
Long-Term Accounts Payable |
261,915,994.47 |
Special Payable |
-- |
Estimatied Liabilities |
327,942,158.95 |
Deferred Income Tax Liabilities |
888,426,481.52 |
Other Non-Current Liabilities |
29,277,300.00 |
Sub-Total of Non-Current Liabilities |
27,067,339,813.33 |
Total Liabilities |
270,933,011,429.73 |
Paid-In Capital(Or Share Stock) |
3,826,558,901.00 |
Capital Surplus |
3,184,825,757.89 |
Surplus Reserve |
986,000,877.68 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
3,833,349,017.59 |
Minority Stockholder's Interest |
13,178,281,743.85 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
13,810,779,031.86 |
Owner's Equity(Stockholder's Equity) |
26,989,060,775.71 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
297,922,072,205.44 |